TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20298539

Group type: EXPERIMENTAL
Intervention: Platelet transfusion within six hours
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Platelet transfusion
Number of subjects: 190
Study: 18630539

Group type: EXPERIMENTAL
Intervention: Acupuncture at single acupoint
Number of subjects: 52
Study: 15830898

Group type: EXPERIMENTAL
Intervention: Problem behavior prevention program
Number of subjects: 2453

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2453
Study: 12612946

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study: 10390223

Group type: EXPERIMENTAL
Intervention: Amprenavir (141W94) 150 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amprenavir (141W94) 300 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amprenavir (141W94) 600 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amprenavir (141W94) 900 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amprenavir (141W94) 1200 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Soft gelatin capsule of amprenavir
Number of subjects: 12
Study: 8708505

Group type: EXPERIMENTAL
Intervention: Regimens containing ofloxacin and rifampicin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Regimens containing rifampicin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ofloxacin and rifampicin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ofloxacin added to WHO recommended M.B.-MDT regimen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 60
Study: 1675881

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 496

Group type: COMPARATOR
Intervention: Ampicillin + Metronidazole
Number of subjects: 496
Study: 6309528

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy
Number of subjects: 30
Study: 30909690

Group type: EXPERIMENTAL
Intervention: Diarrhea after drinking
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Diarrhea after drinking in heavy drinkers
Number of subjects: 417
Study: 29717574

Group type: EXPERIMENTAL
Intervention: artesunate-amodiaquine (ASAQ)
Number of subjects: 240

Group type: COMPARATOR
Intervention: artemether-lumefantrine (AL)
Number of subjects: 240
Study: 27297937

Group type: EXPERIMENTAL
Intervention: Nanohydroxyapatite group (NHA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Pure graft group
Number of subjects: 27
Study: 25276591

Group type: EXPERIMENTAL
Intervention: Oral amoxicillin administered by traditional birth attendants (TBAs)
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Referral to a rural health center facilitated by TBAs
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Referral and/or initiation of antibiotics
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Clinical judgment of 'extremely sick' by TBAs
Number of subjects: 1889
Study: 22817122

Group type: EXPERIMENTAL
Intervention: Sevelamer hydrochloride (SH)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Lanthanum carbonate (LC)
Number of subjects: 42
Study: 20136474

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) applied to supraspinatus and posterior deltoid muscles
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional rehabilitation methods
Number of subjects: 50
Study: 17635310

Group type: EXPERIMENTAL
Intervention: Nutrient-dense formula (NDF)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Energy-supplemented formula (ESF)
Number of subjects: 49
Study: 16298721

Group type: EXPERIMENTAL
Intervention: bupropion hydrochloride
Number of subjects: 600

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 600
Study: 11974558

Group type: EXPERIMENTAL
Intervention: 17 beta-estradiol/levonorgestrel 50/10 micrograms/24 h patch
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: 17 beta-estradiol/levonorgestrel 75/15 micrograms/24 h patch
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: 17 beta-estradiol/levonorgestrel 100/20 micrograms/24 h patch
Number of subjects: 468
Study: 9784666

Group type: EXPERIMENTAL
Intervention: EPO treatment in iron-depleted patients
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo group (iron-replete patients)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Iron-depleted patients
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: EPO therapy in iron-replete patients
Number of subjects: 70
Study: 7722901

Group type: EXPERIMENTAL
Intervention: Self-sealing clear corneal incisions (3.5 mm and 5.2 mm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corneoscleral tunnel incisions (3.5 mm and 5.2 mm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal clear corneal incisions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Superior clear corneal incisions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5.2 mm frown incisions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clear corneal incisions
Number of subjects: 0
Study: 2816798

Group type: EXPERIMENTAL
Intervention: Morning tests
Number of subjects: 10

Group type: COMPARATOR
Intervention: Afternoon tests
Number of subjects: 10
Study: 330474

Group type: EXPERIMENTAL
Intervention: 4 or more metastatic lymph nodes
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1-3 metastatic lymph nodes
Number of subjects: 0
Study: 30236104

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (PR) program for 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual medical care (control)
Number of subjects: 60
Study: 26649464

Group type: EXPERIMENTAL
Intervention: ARC intervention
Number of subjects: 475

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 475
Study: 24144964

Group type: EXPERIMENTAL
Intervention: Subclinical hypothyroidism (n=20, 6.5%)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Subclinical hyperthyroidism (n=5, 1.6%)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Euthyroid subjects (n=280, 91.8%)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Overall mortality risk (TSH values and thyroid disorders)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Overall mortality (n=51, 15.1%)
Number of subjects: 307
Study: 23194310

Group type: EXPERIMENTAL
Intervention: AcrySof ReSTOR SN6AD1 IOL (multifocal IOL)
Number of subjects: 102

Group type: COMPARATOR
Intervention: AcrySof IQ SN60WF IOL (monofocal IOL)
Number of subjects: 102
Study: 20712736

Group type: EXPERIMENTAL
Intervention: Few competitors during referent selection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Two, three, or four competitors during referent selection
Number of subjects: 30
Study: 17403704

Group type: EXPERIMENTAL
Intervention: Cystatin C (cysC) formula for estimating residual glomerular filtration rate (rGFR)
Number of subjects: 465

Group type: COMPARATOR
Intervention: Modification of Diet in Renal Disease (MDRD) formula
Number of subjects: 465
Study: 16422873

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate 40 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 11843276

Group type: EXPERIMENTAL
Intervention: RME only (Group I)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: RME with vertical chin cap (Group II)
Number of subjects: 34
Study: 10411372

Group type: EXPERIMENTAL
Intervention: Increase in hematocrit by 10.99%
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Increased viscosity by 20%
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Physiologic compensation for 20% increased viscosity
Number of subjects: 32
Study: 7572595

Group type: EXPERIMENTAL
Intervention: Diltiazem controlled diffusion (CD) 300 mg
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 2258341

Group type: EXPERIMENTAL
Intervention: Pefloxacin (800 mg single dose)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Co-trimoxazole (960 mg twice daily for 5 days)
Number of subjects: 155
Study: 7273010

Group type: EXPERIMENTAL
Intervention: Weekly regimen of PALA and 5-FU (24 patients)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 5-day regimen of PALA and 5-FU (27 patients)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 51
Study: 31429663

Group type: EXPERIMENTAL
Intervention: One Man Can, a gender-transformative community mobilisation programme
Number of subjects: 0
Study: 31576435

Group type: EXPERIMENTAL
Intervention: Open-lung ventilation strategy (ventilation during CPB, higher PEEP levels of 8 cm H2O)
Number of subjects: 493

Group type: COMPARATOR
Intervention: Conventional ventilation strategy (no ventilation during CPB, lower PEEP levels of 2 cm H2O)
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Open-lung ventilation
Number of subjects: 493

Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 493
Study: 27453426

Group type: EXPERIMENTAL
Intervention: Low-speed rotational atherectomy (140,000 rpm)
Number of subjects: 100

Group type: COMPARATOR
Intervention: High-speed rotational atherectomy (190,000 rpm)
Number of subjects: 100
Study: 25607727

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 23359467

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 32
Study: 21422852

Group type: EXPERIMENTAL
Intervention: Nutritional management with self blood glucose monitoring and insulin as needed
Number of subjects: 460
Study: 19272069

Group type: EXPERIMENTAL
Intervention: Postoperative low-molecular-weight heparin (LMWH)
Number of subjects: 148

Group type: COMPARATOR
Intervention: No postoperative low-molecular-weight heparin (LMWH)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: LMWH the night before surgery
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 148
Study: 16945373

Group type: EXPERIMENTAL
Intervention: Thr‐54 polymorphism of the FABP2 gene
Number of subjects: 776
Study: 15088307

Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10573065

Group type: EXPERIMENTAL
Intervention: Basiliximab (40 mg total: 20 mg on days 0 and 4)
Number of subjects: 169
Study: 8791885

Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% emollient cream (Retinova ‐ Janssen‐Cilag Ltd)
Number of subjects: 0
Study: 1826988

Group type: EXPERIMENTAL
Intervention: Epidural injection of 10-30 micrograms sufentanil added to 0.125% bupivacaine with epinephrine (1:800,000)
Number of subjects: 695

Group type: COMPARATOR
Intervention: Epidural injection of 0.125% bupivacaine with epinephrine (1:800,000) without sufentanil
Number of subjects: 695
Study: 10258418

Group type: EXPERIMENTAL
Intervention: Self-teaching module
Number of subjects: 34

Group type: COMPARATOR
Intervention: Group instruction
Number of subjects: 34
Study: 31277633

Group type: EXPERIMENTAL
Intervention: Physical activity assessment using Global Physical Activity Questionnaire (GPAQ)
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: WHO recommendations of physical activity
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: Recreational activities
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: Correlates of low physical activity
Number of subjects: 945
Study: 28619295

Group type: EXPERIMENTAL
Intervention: Massage therapy (one hour a week during four weeks)
Number of subjects: 29
Study: 24513469

Group type: EXPERIMENTAL
Intervention: Fluorography
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cineangiography
Number of subjects: 50
Study: 22577906

Group type: EXPERIMENTAL
Intervention: Morphine 2.5 mg
Number of subjects: 117

Group type: COMPARATOR
Intervention: Morphine 7.5 mg
Number of subjects: 117
Study: 19937504

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 18008122

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal Saline
Number of subjects: 80
Study: 16153525

Group type: EXPERIMENTAL
Intervention: Color M-mode Doppler assessment of early (Ep) and late (Ap) flow propagation through the left ventricle.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Color M-mode Doppler assessment of early (Ep) and late (Ap) flow propagation through the left ventricle in patients with PSN filling pattern.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control subjects (50 subjects).
Number of subjects: 80
Study: 12653169

Group type: EXPERIMENTAL
Intervention: 20 mg zafirlukast b.i.d.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 10529020

Group type: EXPERIMENTAL
Intervention: Naltrexone with buprenorphine taper (NB Group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Buprenorphine taper alone followed by naltrexone (PB Group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Naltrexone (NB Group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (PB Group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adjunct medication (clonidine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sedatives (up to 20 mg diazepam)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Naltrexone combined with buprenorphine
Number of subjects: 60
Study: 8787262

Group type: EXPERIMENTAL
Intervention: Portex combined spinal-epidural kit
Number of subjects: 100

Group type: COMPARATOR
Intervention: Mallinckrodt combined spinal-epidural kit
Number of subjects: 100
Study: 2032147

Group type: EXPERIMENTAL
Intervention: Alutard SQ (grass pollen depot preparation)
Number of subjects: 0
Study: 6354507

Group type: EXPERIMENTAL
Intervention: Mefloquine (1000 mg given in one day)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Chloroquine (1500 mg given over 3 days)
Number of subjects: 99
Study: 31826920

Group type: EXPERIMENTAL
Intervention: Intermediate femoral cutaneous nerve blockade (IFCNB) combined with proximal femoral triangle block (FTB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Proximal femoral triangle block (FTB) alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Distal femoral triangle block (FTB) combined with IFCNB
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Proximal femoral triangle block (FTB) combined with IFCNB
Number of subjects: 40
Study: 29543552

Group type: EXPERIMENTAL
Intervention: Higher score on the Anglo orientation scale of the Acculturation Rating Scale for Mexican Americans
Number of subjects: 150
Study: 29178740

Group type: EXPERIMENTAL
Intervention: Arginine-based professional paste and arginine-based toothpaste
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoride-free prophylaxis paste and sodium monofluorophosphate toothpaste
Number of subjects: 60
Study: 27129120

Group type: EXPERIMENTAL
Intervention: Test product (20 mg piroxicam capsule)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference product (20 mg piroxicam capsule)
Number of subjects: 24
Study: 22184099

Group type: EXPERIMENTAL
Intervention: Vaccination
Number of subjects: 20
Study: 20646771

Group type: EXPERIMENTAL
Intervention: Honey dressing applied to wounds for 3 months till healing, grafting or failure of treatment.
Number of subjects: 30
Study: 17257466

Group type: EXPERIMENTAL
Intervention: Continuous combined hormone replacement therapy (ccHRT) (Indivina)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lowest dose-combination of ccHRT
Number of subjects: 0
Study: 17723039

Group type: EXPERIMENTAL
Intervention: Novel word labeling
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Novel gesture labeling
Number of subjects: 172

Group type: COMPARATOR
Intervention: No label
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Same word labeling
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Same gesture labeling
Number of subjects: 172
Study: 15160273

Group type: EXPERIMENTAL
Intervention: Biphasic shocks
Number of subjects: 118

Group type: COMPARATOR
Intervention: Monophasic shocks
Number of subjects: 118
Study: 10714047

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 8955759

Group type: EXPERIMENTAL
Intervention: High-flux polysulfone membranes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional low-flux HD membranes
Number of subjects: 20
Study: 1597983

Group type: EXPERIMENTAL
Intervention: Isoproterenol (5 micrograms/kg/min)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (0.08 microgram/kg/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no drugs)
Number of subjects: 30
Study: 6230174

Group type: EXPERIMENTAL
Intervention: Coumadin treatment (prothrombin time 2 to 2.5 times the control value)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Aspirin (325 mg daily)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Coumadin treatment (for patients with at least a 6 month history of angina)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Aspirin (for patients with at least a 6 month history of angina)
Number of subjects: 248
Study: 30826382

Group type: EXPERIMENTAL
Intervention: Symmetric breathing pattern
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Skewed breathing pattern
Number of subjects: 86

Group type: COMPARATOR
Intervention: Watching an emotionally neutral film (sham)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Skewed vagal breathing (experimental group)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Waiting for 2 min (controls)
Number of subjects: 86
Study: 29959266

Group type: EXPERIMENTAL
Intervention: DBS plus optimal drug therapy (DBS + ODT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Optimal drug therapy (ODT)
Number of subjects: 28
Study: 27393540

Group type: EXPERIMENTAL
Intervention: Isoniazid prophylaxis (exact dosage and duration not specified)
Number of subjects: 1351
Study: 24635170

Group type: EXPERIMENTAL
Intervention: Novel polyurethane foam
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control standard foam
Number of subjects: 18
Study: 22266175

Group type: EXPERIMENTAL
Intervention: 1mg oral 17‐β estradiol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Matching placebo pills
Number of subjects: 24
Study: 19237499

Group type: EXPERIMENTAL
Intervention: health promotion intervention
Number of subjects: 878
Study: 17458707

Group type: EXPERIMENTAL
Intervention: Computer-based CDSS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Paper-based CDSS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of computer and paper-based CDSS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Computer-based CDSS in secondary care
Number of subjects: 40

Group type: COMPARATOR
Intervention: Historical control groups in 'before and after' studies
Number of subjects: 40
Study: 15814548

Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.2 mg/kg)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Cyclosporin microemulsion (7 mg/kg)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Rabbit anti-thymocyte globulin (rATG)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 205
Study: 11910310

Group type: EXPERIMENTAL
Intervention: atenolol 50 mg/day
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: trandolapril 2 mg/day
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: verapamil 240 mg/day
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: verapamil 180 + trandolapril 2 mg/day combination
Number of subjects: 119
Study: 9426828

Group type: EXPERIMENTAL
Intervention: 10 mg CPA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CPA (10-150 mg)
Number of subjects: 0
Study: 8131255

Group type: EXPERIMENTAL
Intervention: Mefloquine alone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mefloquine in combination with artesunate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Artesunate effect on mefloquine pharmacokinetics
Number of subjects: 20
Study: 2643892

Group type: EXPERIMENTAL
Intervention: Halothane at 0.5, 0.75, and 1 MAC in 60% N2O
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Enflurane at 0.5, 0.75, and 1 MAC in 60% N2O
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Isoflurane at 0.5, 0.75, and 1 MAC in 60% N2O
Number of subjects: 28
Study: 772653

Group type: EXPERIMENTAL
Intervention: Xanthinol nicotinate ('Complamin'; 'Complamex')
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 31998472

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT) consisting of two high-velocity low-amplitude spinal manipulations and two grade IV mobilizations of the lumbar spine and pelvis
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT)
Number of subjects: 40
Study: 30759101

Group type: EXPERIMENTAL
Intervention: Creative arts in psychotherapy (10-session group programme)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Low-level supportive programme (control condition)
Number of subjects: 125
Study: 27709762

Group type: EXPERIMENTAL
Intervention: Faster-acting insulin aspart (faster aspart)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Insulin aspart (IAsp)
Number of subjects: 48
Study: 25649543

Group type: EXPERIMENTAL
Intervention: Traumeel 2 ml injection
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg injection
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 160
Study: 24351013

Group type: COMPARATOR
Intervention: Distraction by STROOP test
Number of subjects: 34

Group type: COMPARATOR
Intervention: Heterotopic foot stimulation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Heterotopic stimulation
Number of subjects: 34
Study: 21406601

Group type: EXPERIMENTAL
Intervention: lisinopril 10 to 20 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: lisinopril 10 to 20 mg/d plus simvastatin 20 mg/d
Number of subjects: 0
Study: 19165592

Group type: EXPERIMENTAL
Intervention: Family-focused cognitive behavioral therapy (FCBT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Child-focused cognitive behavioral therapy (CCBT)
Number of subjects: 35
Study: 17890444

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day for 3 days before MDMA challenge (100 mg oral)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12